We provide bespoke early phase, end-to-end biometrics services from strategic decision support, protocol development to analysis and reporting and stakeholder engagement.
The development of investigational drugs is a complex, expensive and time-consuming process with many risks. Optimising the opportunity for success at every step is crucial – one miscalculation can lead to delays, additional cost and loss of stakeholder support.
Our proven expertise in early phase studies supports effective decision-making reducing development time, cost and risk at each phase of development.
Our unique combination of our KerusCloud software with our early phase services enables our client big and small to have immediate access to powerful simulations and highly-trained staff to expedite development.
Other Areas of Expertise
We can further support your project with these additional areas of expertise.
If you’d like to find out more, just fill in this form and we’ll send you more detailed information.
Alternatively you can get in touch with us directly.